Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 1/2021

01-01-2021 | Prostate Cancer | Correction

Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

Authors: Thomas Wiegel, Peter Albers, Detlef Bartkowiak, Roswitha Bussar-Maatz, Martin Härter, Glen Kristiansen, Peter Martus, Stefan Wellek, Heinz Schmidberger, Klaus Grozinger, Peter Renner, Fried Schneider, Martin Burmester, Michael Stöckle

Published in: Journal of Cancer Research and Clinical Oncology | Issue 1/2021

Login to get access

Excerpt

In the original article published, the figure 3a displays early toxicity in patients of the PREFERE trial with active treatment. This figure was incorrect and has been corrected in this erratum. …
Metadata
Title
Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
Authors
Thomas Wiegel
Peter Albers
Detlef Bartkowiak
Roswitha Bussar-Maatz
Martin Härter
Glen Kristiansen
Peter Martus
Stefan Wellek
Heinz Schmidberger
Klaus Grozinger
Peter Renner
Fried Schneider
Martin Burmester
Michael Stöckle
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 1/2021
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-020-03497-z

Other articles of this Issue 1/2021

Journal of Cancer Research and Clinical Oncology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine